{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:01:52Z","timestamp":1785250912009,"version":"3.55.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Heart failure (HF) is a global health challenge with increasing burden. This study characterized HF across different severity levels to inform service delivery and health system responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Using Global Burden of Disease (GBD) Study 2021 data, we analyzed age-standardized rates of prevalence and years lived with disability (YLDs) for HF, stratified into four levels based on symptom severity as determined by the GBD: treated, mild, moderate and severe. Estimates were stratified by sex, region, and underlying causes. Spearman's rank correlation tests were used to assess the relationships between burden and sociodemographic index (SDI) and universal health coverage (UHC). Temporal trends and contributions were evaluated using estimated annual percentage changes and decomposition analyses. The overall prevalence of HF was 55.5 million (M), and using GBD symptom severity categories, there were 20.5\u2005M treated HF globally in 2021, resulting in 1.3\u2005M YLDs. Mild HF was 10.3\u2005M (0.4\u2005M YLDs), moderate HF was 6.7\u2005M (0.5\u2005M YLDs), and severe HF was 18.0\u2005M (3.1\u2005M YLDs). Ischaemic heart disease remained the leading underlying cause of HF. Males experienced a burden 25% higher than females. Geographic variation was observed, with higher YLDs due to treated HF correlating with lower SDI and UHC levels, while no significant association for mild, moderate, or severe HF. During 1990\u20132021, prevalence and YLDs increased across all groups with an increase of 0.2%, predominantly driven by population growth and ageing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The burden of HF is projected to rise significantly. Advancing strategies to strengthen health systems and address disparities in access to guideline-directed care, particularly in low- and middle-income countries, is an important focus for action.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjcn\/zvag158","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T06:05:21Z","timestamp":1783749921000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence, symptom severity and years lived with the disability of heart failure, and their implications on health systems: a population-based comparative study"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0643-9191","authenticated-orcid":false,"given":"Jialing","family":"Lin","sequence":"first","affiliation":[{"name":"International Centre for Future Health Systems, University of New South Wales , 55 Botany Street, Randwick, NSW 2031 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8960-7761","authenticated-orcid":false,"given":"Chuyi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Research Department of Epidemiology and Public Health, University College London , 1-19 Torrington Place, London, WC1E 7HB ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8783-8919","authenticated-orcid":false,"given":"Jinfeng","family":"Ding","sequence":"additional","affiliation":[{"name":"Xiangya School of Nursing, Central South University , 172 Tongzibo Road, Yuelu District, Changsha 410013 ,","place":["China"]},{"name":"School of Global and Population Health, The University of Western Australia , 35 Stirling Highway Crawley, Perth, WA 6009 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6115-0326","authenticated-orcid":false,"given":"David","family":"Brieger","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Concord Repatriation General Hospital , Hospital Road, Concord, NSW 2139 ,","place":["Australia"]},{"name":"Faculty of Medicine and Health, University of Sydney , Western Avenue, Camperdown, NSW 2050 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5233-2758","authenticated-orcid":false,"given":"Joel J","family":"Rhee","sequence":"additional","affiliation":[{"name":"Discipline of General Practice, School of Clinical Medicine, UNSW Sydney , 55 Botany Street, Randwick, NSW 2031 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6110-2447","authenticated-orcid":false,"given":"Jennifer","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Prince of Wales Hospital, South Eastern Sydney Local Health District , Barker Street, Randwick, NSW 2031 ,","place":["Australia"]},{"name":"School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales , 55 Botany Street, Randwick, NSW 2031 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4554-7451","authenticated-orcid":false,"given":"Zi","family":"Ye","sequence":"additional","affiliation":[{"name":"Discipline of General Practice, School of Clinical Medicine, UNSW Sydney , 55 Botany Street, Randwick, NSW 2031 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5704-5782","authenticated-orcid":false,"given":"Junchen","family":"Guo","sequence":"additional","affiliation":[{"name":"School of Nursing, University of Wollongong , Northfields Ave, Wollongong, NSW 2522 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8666-082X","authenticated-orcid":false,"given":"Zhishan","family":"Xie","sequence":"additional","affiliation":[{"name":"Faculty of Science, Medicine and Health, University of Wollongong , Northfields Ave, Wollongong, NSW 2522 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5287-7003","authenticated-orcid":false,"given":"Xiwen","family":"Qin","sequence":"additional","affiliation":[{"name":"School of Global and Population Health, The University of Western Australia , 35 Stirling Highway Crawley, Perth, WA 6009 ,","place":["Australia"]},{"name":"Department of Public Health and Preventive Medicine, School of Medicine, Jinan University , 601 West Huangpu Road, Tianhe District, Guangzhou, Guangdong 510632 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0221-1245","authenticated-orcid":false,"given":"Michael","family":"Kidd","sequence":"additional","affiliation":[{"name":"International Centre for Future Health Systems, University of New South Wales , 55 Botany Street, Randwick, NSW 2031 ,","place":["Australia"]},{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford , Woodstock Rd, Oxford OX1 2JD ,","place":["United Kingdom"]},{"name":"College of Health & Medicine, Australian National University , Linnaeus Way, Canberra, ACT 2601 ,","place":["Australia"]},{"name":"Department of Family and Community Medicine, University of Toronto , 500 University Ave, Toronto, Ontario M5G 1V7 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2050-1534","authenticated-orcid":false,"given":"Patricia M","family":"Davidson","sequence":"additional","affiliation":[{"name":"International Centre for Future Health Systems, University of New South Wales , 55 Botany Street, Randwick, NSW 2031 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"2026072810190654100_zvag158-B1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026072810190654100_zvag158-B2","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2026072810190654100_zvag158-B3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12872-018-0815-3","article-title":"Cost-of-illness studies in heart failure: a systematic review 2004\u20132016","volume":"18","author":"Lesyuk","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"2026072810190654100_zvag158-B4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"HF STATS 2024: heart failure epidemiology and outcomes statistics an updated 2024 report from the heart failure society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J Card Fail"},{"key":"2026072810190654100_zvag158-B5","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"2026072810190654100_zvag158-B6","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","journal-title":"The Lancet"},{"key":"2026072810190654100_zvag158-B7","first-page":"352","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure","volume":"23","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"key":"2026072810190654100_zvag158-B8","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14098","article-title":"Changing trends in the prevalence of heart failure impairment with Thalassemias over three decades","volume":"54","author":"Tang","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"2026072810190654100_zvag158-B9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40364-025-00728-8","article-title":"Global, regional, and national burden of heart failure and its underlying causes, 1990\u20132021: results from the global burden of disease study 2021","volume":"13","author":"Ran","year":"2025","journal-title":"Biomark Res"},{"key":"2026072810190654100_zvag158-B10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2021.09.015","article-title":"Changing age-specific trends in incidence, comorbidities and mortality of hospitalised heart failure in Western Australia between 2001 and 2016","volume":"343","author":"Weber","year":"2021","journal-title":"Int J Cardiol"},{"key":"2026072810190654100_zvag158-B11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.pu.16.050195.000425","article-title":"Ecologic studies in epidemiology: concepts, principles, and methods","volume":"16","author":"Morgenstern","year":"1995","journal-title":"Annu Rev Public Health"},{"key":"2026072810190654100_zvag158-B12","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for accurate and transparent health estimates reporting: the GATHER statement","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet"},{"key":"2026072810190654100_zvag158-B13","author":"Institute for Health Metrics and Evaluation (IHME)"},{"key":"2026072810190654100_zvag158-B14","author":"World Health Organization"},{"key":"2026072810190654100_zvag158-B15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216613","article-title":"A new method to attribute differences in total deaths between groups to population size, age structure and age-specific mortality rate","volume":"14","author":"Cheng","year":"2019","journal-title":"PLoS One"},{"key":"2026072810190654100_zvag158-B16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ejhf.486","article-title":"Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study","volume":"18","author":"Schmidt","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026072810190654100_zvag158-B17","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990\u20132022","volume":"82","author":"Mensah","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026072810190654100_zvag158-B18","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/eurheartj\/ehac103","article-title":"Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction","volume":"43","author":"Tromp","year":"2022","journal-title":"Eur Heart J"},{"key":"2026072810190654100_zvag158-B19","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1002\/ehf2.13646","article-title":"Time is prognosis\u2019 in heart failure: time-to-treatment initiation as a modifiable risk factor","volume":"8","author":"Abdin","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026072810190654100_zvag158-B20","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/heartjnl-2016-310913","article-title":"Capacity for diagnosis and treatment of heart failure in sub-saharan Africa","volume":"103","author":"Carlson","year":"2017","journal-title":"Heart"},{"key":"2026072810190654100_zvag158-B21","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00228-023-03539-8","article-title":"Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014\u20132022)","volume":"79","author":"Lin","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"key":"2026072810190654100_zvag158-B22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032296","article-title":"Time to SGLT2 inhibitor initiation in patients with heart failure","volume":"13","author":"Moon","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026072810190654100_zvag158-B23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12872-024-03961-5","article-title":"Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013\u20132021","volume":"24","author":"Gonzalez","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"2026072810190654100_zvag158-B24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5334\/gh.1355","article-title":"Use of guideline-recommended heart failure drugs in high-, middle-, and low-income countries: a systematic review and meta-analysis","volume":"19","author":"Satheesh","year":"2024","journal-title":"Glob Heart"},{"key":"2026072810190654100_zvag158-B25","doi-asserted-by":"crossref","first-page":"17539447231202933","DOI":"10.1177\/17539447231202933","article-title":"The usage of SGLT-2 inhibitors in the management of heart failure in rural Africa: mitigating the barriers to the optimal adoption of a novel, adjuvant therapeutic agent in the management of heart failure","volume":"17","author":"Ashinze","year":"2023","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"2026072810190654100_zvag158-B26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"key":"2026072810190654100_zvag158-B27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1053\/j.semnuclmed.2020.02.007","article-title":"Ischemic heart disease: an update","volume":"50","author":"Jensen","year":"2020","journal-title":"Semin Nucl Med"},{"key":"2026072810190654100_zvag158-B28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cjco.2023.05.008","article-title":"Heart failure management in 2023: a pharmacotherapy- and lifestyle-focused comparison of current international guidelines","volume":"5","author":"MacDonald","year":"2023","journal-title":"CJC Open"},{"key":"2026072810190654100_zvag158-B29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jchf.2019.03.011","article-title":"Sex-based differences in heart failure across the ejection fraction spectrum: phenotyping, and prognostic and therapeutic implications","volume":"7","author":"Stolfo","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2026072810190654100_zvag158-B30","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","article-title":"Sex differences in heart failure","volume":"40","author":"Lam","year":"2019","journal-title":"Eur Heart J"},{"key":"2026072810190654100_zvag158-B31","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"2026072810190654100_zvag158-B32","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(20)30677-2","article-title":"Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study","volume":"396","author":"Vollset","year":"2020","journal-title":"Lancet"},{"key":"2026072810190654100_zvag158-B33","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(25)01393-5","article-title":"Prioritising the primary prevention of heart failure","volume":"406","author":"Khan","year":"2025","journal-title":"Lancet"},{"key":"2026072810190654100_zvag158-B34","first-page":"100950","article-title":"Subclinical myocardial injury, coagulopathy, and inflammation in COVID-19: a meta-analysis of 41,013 hospitalized patients","volume":"40","author":"Ogungbe","year":"2022","journal-title":"Int J Cardiol Heart Vasc"}],"container-title":["European Journal of Cardiovascular Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjcn\/advance-article-pdf\/doi\/10.1093\/eurjcn\/zvag158\/68757790\/zvag158.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjcn\/advance-article-pdf\/doi\/10.1093\/eurjcn\/zvag158\/68757790\/zvag158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:38:36Z","timestamp":1785249516000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjcn\/advance-article\/doi\/10.1093\/eurjcn\/zvag158\/8732344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1093\/eurjcn\/zvag158","relation":{},"ISSN":["1474-5151","1873-1953"],"issn-type":[{"value":"1474-5151","type":"print"},{"value":"1873-1953","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"article-number":"zvag158"}}